Search Results 1281-1290 of 17124 for monoclonal antibody

1. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

   ... antibody in combination in the same line or separate lines of treatment OR refractory to PI, IMiD and CD38-directed antibody; Note: Subjects enrolled in the ...

2. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

   ... monoclonal antibody as appropriate for the disease): * Ifosfamide/carboplatin/etoposide (ICE) or rituximab/ifosfamide/carboplatin/etoposide (RICE);

3. A Study to Assess False Positive HIV-2 Testing - Mayo Clinic

   To describe the demographics and comorbidities of patients with false positive testing for HIV-1 and HIV 2 (defined as positive or indeterminate antibody ...

4. Clinical trials - Oncology (Medical)

   ... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Accelerated vs Standard BEP ...

5. A Study to Assess the Safety and Dose Escalation of Pegtomarginase (PT01) for Subjects with Advanced Malignancies - Mayo Clinic

   Chemotherapy, immunotherapy, hormonal therapy, and monoclonal antibodies (but excluding nitrosourea, mitomycin-C, targeted therapy) ≤ 28 days prior to ...

6. Cell Therapy Clinical Trials

   ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study to Analyze AVB-114 to Treat Complex Crohn's ...

7. Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

   Tests positive for HIV-1 antibody and HIV-2 antibody, human T-lymphotropic virus 1 antibody, HBs antigen, or HCV antibody. Tests positive for HBs antibody or ...

8. A Study to Investigate Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache - Mayo Clinic

   Has previously received any CGRP ligand or receptor targeted monoclonal antibody. Eligibility last updated 1/19/22. Questions regarding updates should be ...

9. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients - Mayo Clinic

   ... antibodies against their donors are at a greater risk of rejection of their transplanted organs. Participation eligibility. Participant eligibility includes ...

10. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    Known allergies, hypersensitivity, or intolerance to monoclonal antibodies, hyaluronidase, human proteins, or their excipients (refer to IB), or known ...